Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors

Fig. 1

Changes of ctDNA could predict the response to immunotherapy. a The landscape of high-frequency genomic alterations detected in 34 paired tissue and baseline plasma samples. b Patients who had a > 25% decline in maxVAF had a significant longer PFS than those that did not. c Patients with undetectable ctDNA of post-treatment plasma samples had a better PFS. d Waterfall plot of best radiologic response and ctDNA response (Only changes of measurable tumors were displayed in this figure). maxVAF, maximal somatic variant allelic frequency

Back to article page

Molecular Cancer

ISSN: 1476-4598